炎症性肠病相关结直肠癌对手术结局和医疗费用产生负面影响
基于2018至2021年Medicare索赔数据,在191,684例结直肠癌患者中4,770例(2.5%)合并炎症性肠病。合并炎症性肠病者接受手术切除的比例较低(无炎症性肠病47.6% vs 有炎症性肠病42.1%,P<.001),术后达到理想结局的比值比较低(OR 0.64 [95%CI 0.58-0.70]),术后并发症、延长住院和90天再入院的比值比较高,出院回家独立护理的比值比较低(OR 0.77 [0.68-0.87]),支出高12.2%。
要点
- 结直肠癌患者中约2.5%合并炎症性肠病,合并者接受手术切除的比例较低(47.6% vs 42.1%,P<.001)。
- 合并炎症性肠病者术后达到理想结局的比值比较低(OR 0.64 [95%CI 0.58-0.70])。
- 合并炎症性肠病者术后并发症、延长住院和90天再入院的比值比较高,出院回家独立护理的比值比较低(OR 0.77 [0.68-0.87]),支出高12.2%。
核心结论
- 炎症性肠病与结直肠癌术后达到理想结局的概率较低、出院后支出较高以及长期生存较差相关。
研究设计与样本
- 基于2018至2021年Medicare索赔数据的回顾性研究,纳入191,684例结直肠癌患者,其中4,770例(2.5%)合并克罗恩病或溃疡性结肠炎。
主要发现
- 合并炎症性肠病者接受手术切除的比例为42.1%,无炎症性肠病者为47.6%(P<.001)。
- 在接受了结直肠手术的患者中,合并炎症性肠病者达到理想结局的比值比较低(OR 0.64 [95%CI 0.58-0.70])。
- 合并炎症性肠病者术后并发症的比值比较高(OR 1.24 [95%CI 1.12-1.38]),延长住院的比值比较高(OR 1.41 [95%CI 1.27-1.58]),90天内再入院的比值比较高(OR 1.56 [95%CI 1.42-1.72])(均P<.05)。
- 合并炎症性肠病者出院回家独立护理的比值比较低(OR 0.77 [95%CI 0.68-0.87]),支出高12.2%,且支出与是否达到理想结局相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inflammatory bowel disease may affect the pathogenesis and clinicopathologic course of colorectal cancer. We sought to characterize the impact of inflammatory bowel disease on outcomes after colectomy and/or proctectomy for a malignant indication. METHODS: Patients diagnosed with colorectal cancer as well as a pre-existing comorbid diagnosis of Crohn's disease or ulcerative colitis between 2018 and 2021 were identified from Medicare claims data. The postoperative textbook outcome was defined as the absence of complications, as well as no extended hospital stay, 90-day readmission, or mortality. Postdischarge disposition and expenditures were also examined. RESULTS: Among 191,684 patients with colorectal cancer, 4,770 (2.5%) had a pre-existing diagnosis of inflammatory bowel disease. Patients with inflammatory bowel disease-associated colorectal cancer were less likely to undergo surgical resection (no inflammatory bowel disease: 47.6% vs inflammatory bowel disease: 42.1%; P < .001). Among patients who did undergo colorectal surgery, individuals with inflammatory bowel disease were less likely to achieve a textbook outcome (odds ratio 0.64 [95% confidence interval 0.58-0.70]). In particular, patients with inflammatory bowel disease had higher odds of postoperative complications (odds ratio 1.24 [1.12-1.38]), extended hospital stay (odds ratio 1.41 [1.27-1.58]), and readmission within 90 days (odds ratio 1.56 [1.42-1.72]) (all P < .05). Patients with inflammatory bowel disease-associated colorectal cancer were less likely to be discharged to their home under independent care (odds ratio 0.77 [0.68-0.87]) and had 12.2% higher expenditures, which correlated with whether the patient had a postoperative textbook outcome. CONCLUSION: One in 40 patients with colorectal cancer had concomitant inflammatory bowel disease. Inflammatory bowel disease was associated with a lower probability of achieving ideal postoperative outcomes, higher postdischarge expenditure, as well as worse long-term survival after colorectal cancer resection.
引用
- Katayama ES, Woldesenbet S, Tsilimigras D, et al. Inflammatory bowel disease-associated colorectal cancer negatively affects surgery outcomes and health care costs. Surgery. 2024. PMID: 38582731. doi:10.1016/j.surg.2024.03.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。